Document Detail

Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction.
MedLine Citation:
PMID:  20171995     Owner:  NLM     Status:  MEDLINE    
Circulating ghrelin concentration regulates appetite behavior, but no study thus far has focused on the role of central ghrelin in anorexia after chemotherapy. To clarify the action mechanisms of rikkunshito (RKT), a traditional Japanese medicine, on cisplatin-induced anorexia, we attempted to elucidate its effect on hypothalamic ghrelin receptor expression in cisplatin-induced anorexia. We first examined the effects of an intracerebroventricular (ICV) injection of exogenous ghrelin on food intake with or without cisplatin treatment, and the effects of cisplatin or m-chlorophenylpiperazine (mCPP), a 5-HT2C receptor agonist, on hypothalamic growth hormone secretagogue receptor 1a (GHS-R1a) mRNA expression. To identify the mechanism of cisplatin-induced decrease in hypothalamic GHS-R1a mRNA expression, we evaluated the effects of SB242084HCl, a 5-HT2C receptor antagonist, and RKT on hypothalamic GHS-R1a gene expression, along with the effect of coadministration of a GHS-R1a antagonist on decreased food intake. Compared to vehicle controls, an ICV-injected rat ghrelin failed to inhibit the decrease in food intake in cisplatin-treated rats. Hypothalamic GHS-R1a gene expression was significantly reduced after cisplatin or mCPP treatment, and the induced decrease was reversed by SB242084HCl or RKT, but not granisetron or ondansetron, both of which are 5-HT3 receptor antagonists. Their suppressive effect on the decrease in food intake was abolished by coadministration of the GHS-R1a antagonist. Administration of RKT or SB242084HCl reversed the decrease in food intake induced by mCPP injection. The improvement by RKT on decreased food intake after cisplatin treatment was partly mediated by hesperidin and isoliquiritigenin, components of RKT. Cisplatin-induced anorexia may worsen because of decreased hypothalamic GHS-R1a gene expression. A 5-HT2C receptor antagonist and RKT suppressed cisplatin-induced anorexia by inhibiting reduction of GHS-R1a signal transduction in the hypothalamus.
Koji Yakabi; Susumu Kurosawa; Mitsuo Tamai; Mitsutoshi Yuzurihara; Miwa Nahata; Shino Ohno; Shoki Ro; Shingo Kato; Toru Aoyama; Tomoya Sakurada; Hidehiko Takabayashi; Tomohisa Hattori
Related Documents :
12130565 - Eating elicited by orexin-a, but not melanin-concentrating hormone, is opioid mediated.
19523445 - Central lactate metabolism suppresses food intake via the hypothalamic amp kinase/malon...
17033095 - Influence of ghrelin on gastric and duodenal growth and expression of digestive enzymes...
19297235 - Ghrelin: a metabolic signal affecting the reproductive system.
15270495 - Distribution of listeria monocytogenes molecular subtypes among human and food isolates...
1478315 - The relationship between central nuclear scatter and perinuclear retrodots in the human...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-02-19
Journal Detail:
Title:  Regulatory peptides     Volume:  161     ISSN:  1873-1686     ISO Abbreviation:  Regul. Pept.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-03-30     Completed Date:  2010-07-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8100479     Medline TA:  Regul Pept     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  97-105     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier B.V. All rights reserved.
Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, 1981 Tsujido-machi, Kamoda, Kawagoe-city, Saitama 350-8550, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anorexia / chemically induced*,  drug therapy*
Cisplatin / pharmacology*
Drugs, Chinese Herbal / therapeutic use*
Eating / drug effects,  genetics
Ghrelin / metabolism*
Granisetron / pharmacology
Hypothalamus / drug effects,  metabolism*
Oligopeptides / genetics
Ondansetron / pharmacology
Quinoxalines / pharmacology
Rats, Sprague-Dawley
Receptor, Serotonin, 5-HT2C / antagonists & inhibitors*
Receptors, Ghrelin / genetics
Reverse Transcriptase Polymerase Chain Reaction
Stomach / drug effects,  metabolism
Reg. No./Substance:
0/Drugs, Chinese Herbal; 0/Ghrelin; 0/Oligopeptides; 0/Quinoxalines; 0/Receptor, Serotonin, 5-HT2C; 0/Receptors, Ghrelin; 0/liu-jun-zi-tang; 109028-10-6/CGS 12066B; 109889-09-0/Granisetron; 15663-27-1/Cisplatin; 99614-02-5/Ondansetron

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Distribution of a novel binding site for angiotensins II and III in mouse tissues.
Next Document:  Ghrelin promotes antioxidant enzyme activity and reduces lipid peroxidation in the rat ovary.